دورية أكاديمية

Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria

التفاصيل البيبلوغرافية
العنوان: Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
المؤلفون: Marjan Afrouzian, Nicolas Kozakowski, Helen Liapis, Verena Broecker, Luon Truong, Carmen Avila-Casado, Heinz Regele, Surya Seshan, Josephine M. Ambruzs, Alton Brad Farris, David Buob, Praveen N. Chander, Lukman Cheraghvandi, Marian C. Clahsen-van Groningen, Stanley de Almeida Araujo, Dilek Ertoy Baydar, Mark Formby, Danica Galesic Ljubanovic, Loren Herrera Hernandez, Eva Honsova, Nasreen Mohamed, Yasemin Ozluk, Marion Rabant, Virginie Royal, Heather L. Stevenson, Maria Fernanda Toniolo, Diana Taheri
المصدر: Transplant International, Vol 36 (2023)
بيانات النشر: Frontiers Media S.A., 2023.
سنة النشر: 2023
المجموعة: LCC:Specialties of internal medicine
مصطلحات موضوعية: thrombotic microangiopathy, kidney, transplant, pathology criteria, Delphi, Banff, Specialties of internal medicine, RC581-951
الوصف: The Banff community summoned the TMA Banff Working Group to develop minimum diagnostic criteria (MDC) and recommendations for renal transplant TMA (Tx-TMA) diagnosis, which currently lacks standardized criteria. Using the Delphi method for consensus generation, 23 nephropathologists (panelists) with >3 years of diagnostic experience with Tx-TMA were asked to list light, immunofluorescence, and electron microscopic, clinical and laboratory criteria and differential diagnoses for Tx-TMA. Delphi was modified to include 2 validations rounds with histological evaluation of whole slide images of 37 transplant biopsies (28 TMA and 9 non-TMA). Starting with 338 criteria in R1, MDC were narrowed down to 24 in R8 generating 18 pathological, 2 clinical, 4 laboratory criteria, and 8 differential diagnoses. The panelists reached a good level of agreement (70%) on 76% of the validated cases. For the first time in Banff classification, Delphi was used to reach consensus on MDC for Tx-TMA. Phase I of the study (pathology phase) will be used as a model for Phase II (nephrology phase) for consensus regarding clinical and laboratory criteria. Eventually in Phase III (consensus of the consensus groups) and the final MDC for Tx-TMA will be reported to the transplantation community.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1432-2277
العلاقة: https://www.frontierspartnerships.org/articles/10.3389/ti.2023.11590/fullTest; https://doaj.org/toc/1432-2277Test
DOI: 10.3389/ti.2023.11590
الوصول الحر: https://doaj.org/article/e101ede6be324704a1a6619ba7988739Test
رقم الانضمام: edsdoj.101ede6be324704a1a6619ba7988739
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14322277
DOI:10.3389/ti.2023.11590